The NCI biospecimen research network

Biotechnic and Histochemistry

Volumn 87, Issue 1, 2012, Pages 18-23

  Moore, H M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Best practices; Biobank; Biospecimen; Cancer; Human; Quality; Research

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; HEALTH CARE FACILITY; HUMAN; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PRACTICE GUIDELINE; QUALITY CONTROL; STANDARD; UNITED STATES;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY CONTROL; SPECIMEN HANDLING; UNITED STATES;

EID: 83755224707     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2011.591833     Document Type: Article

References (14)

1. Barton RH, Nicholson JK, Elliott P, Holmes E (2008) High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: Validation study. Int. J. Epidemiol. 37 Suppl. 1: 31-40.
2. Compton C (2007) Getting to personalized cancer medicine: Taking out the garbage. Cancer 110: 1641-1643. (Pubitemid 47557286)
3. De Cecco L, Musella V, Veneroni S, Cappelletti V, Bongarzone I, Callari M, Valeri B, Pierotti MA, Daidone MG (2009) Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer 9: 409.
4. Engel KB and Moore HM (2011) Effects of preanalytic variables on the detection of proteins by immunohistochemistry in formalin-fi xed, paraffi n-embedded tissue. Arch Pathol Lab Med. 135: 537-43.
5. Lips EH, Dierssen JW, van Eijk R, Oosting J, Eilers PH, Tollenaar RA, de Graaf EJ, van't Slot R, Wijmenga C, Morreau H, van Wezel T (2005) Reliable highthroughput genotyping and loss-of-heterozygosity detection in formalin-fi xed, paraffi n-embedded tumors using single nucleotide polymorphism arrays. Cancer Res. 65: 10188-10191. (Pubitemid 41743709)
6. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Statistics Subcommitteeof the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK). J. Natl. Cancer Inst. 97: 1180-1184.
7. Moore HM, Compton CC, Lim MD, Vaught J, Christiansen KN, Alper J (2009) 2009 Biospecimen research network symposium: Advancing cancer research through biospecimen science. Cancer Res. 69: 6770-6772.
8. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfi eld E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier H-U, Zhu C, Vaught J (2011) Biospecimen reporting for improved study quality (BRISQ). Biopreserv. Biobanking. 9: 57-70.
9. Cancer Cytopathol. 119: 92-102.
10. J. Proteome. Res. May 16. [Epub ahead of print].
11. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, Schulz-Knappe P, Speicher DW, Vitzthum F, Haab BB, Siest G, Chan DW (2005) HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 5: 3262-3277. (Pubitemid 41192034)
12. Schlomm T, Näkel E, Lübke A, Buness A, Chun FK, Steuber T, Graefen M, Simon R, Sauter G, Poustka A, Huland H, Erbersdobler A, S ü ltmann H, Hellwinkel OJ (2008) Marked gene transcript level alterations occur early during radical prostatectomy. Eur. Urol. 53: 333-344.
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2008) STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61: 344-349. (Pubitemid 351289042)
14. Williams JH, Mepham BL, Wright DH (1997) Tissue preparation for immunocytochemistry. J. Clin. Pathol. 50: 422-428. (Pubitemid 27278448)